Brief: Eagle Pharmaceuticals Reaches Bendeka Settlement Agreement With Accord Healthcare
12/12/2022 15:12
Dec 12 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS REACHES SETTLEMENT AGREEMENT WITH
ACCORD
HEALTHCARE, INC. RELATED TO BENDEKA® (BENDAMUSTINE
HYDROCHLORIDE)
* EAGLE PHARMACEUTICALS INC - AGREEMENT PROVIDES THAT ACCORD
HAS
RIGHT TO MARKET ITS PRODUCT BEGINNING JAN 17, 2028, OR EARLIER
BASED ON CERTAIN CIRCUMSTANCES
* EAGLE PHARMACEUTICALS INC - SETTLEMENT AGREEMENT IS
CONFIDENTIAL, SUBJECT TO REVIEW BY U.S. FEDERAL TRADE COMMISSION
AND U.S. DEPARTMENT OF JUSTICE
Source text for Eikon: ID:nGNX53dSvF
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq